GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

ST Pharm Co 237690.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

71,500

-1.52%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩331.68bn

FY2016FY2025

Net income

₩54.99bn

FY2016FY2025

Free cash flow

−₩33.30bn

FY2016FY2025

Shareholders' equity

₩593.44bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩331.68bn₩273.75bn₩284.99bn₩249.32bn₩165.64bn₩124.11bn₩93.26bn₩97.74bn₩202.80bn₩200.36bn
Research and development₩23.71bn₩22.11bn₩30.45bn₩26.31bn₩18.22bn₩13.20bn₩15.06bn₩8.77bn₩9.66bn₩8.58bn
Operating income₩58.80bn—₩33.46bn—₩5.58bn−₩18.82bn−₩26.70bn−₩15.65bn₩61.17bn₩77.56bn
Net income₩54.99bn₩34.71bn₩19.58bn₩18.00bn₩3.31bn−₩12.15bn−₩18.53bn−₩9.27bn₩45.00bn₩61.43bn
Diluted earnings per share2,656.951,722.421,041.07957.00176.09-651.11-993.18-496.782,334.773,323.12

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩782.57bn₩721.88bn₩675.44bn₩570.65bn₩498.57bn₩445.57bn₩341.08bn₩345.51bn₩381.50bn₩367.78bn
Cash and short-term investments—₩120.92bn₩90.10bn₩50.20bn₩93.22bn₩140.64bn₩65.04bn₩107.71bn₩132.30bn₩115.20bn
Total liabilities₩189.56bn₩218.88bn₩288.53bn₩233.02bn₩175.59bn₩150.24bn₩40.12bn₩13.94bn₩30.42bn₩54.53bn
Debt—₩118.14bn₩192.08bn₩134.52bn₩107.52bn₩126.93bn₩15.99bn₩117.0m₩137.0m₩1.52bn
Shareholders' equity₩593.44bn₩503.13bn₩384.55bn₩337.63bn₩322.97bn₩295.33bn₩300.96bn₩331.57bn₩351.08bn₩313.24bn
Shares outstanding21m20m19m19m19m19m19m19m19m18m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩13.99bn₩109.45bn₩1.30bn₩7.03bn₩7.27bn−₩20.93bn−₩30.52bn₩10.77bn₩54.44bn₩50.78bn
Capital spending−₩47.29bn−₩83.22bn−₩43.44bn−₩60.66bn−₩51.79bn−₩16.99bn−₩6.22bn−₩27.17bn−₩27.70bn−₩16.03bn
Free cash flow−₩33.30bn₩26.23bn−₩42.14bn−₩53.63bn−₩44.52bn−₩37.92bn−₩36.74bn−₩16.40bn₩26.74bn₩34.75bn
Dividends paid−₩10.08bn−₩9.40bn−₩9.40bn−₩9.40bn——−₩9.33bn−₩9.33bn−₩9.24bn−₩2.95bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩108.48bn₩66.96bn₩129.10bn₩81.91bn₩68.25bn₩52.42bn₩115.74bn₩61.70bn
Operating income₩18.31bn₩11.53bn₩30.48bn₩14.72bn₩12.44bn₩1.03bn₩22.78bn₩6.10bn
Net income₩13.21bn₩15.06bn₩30.95bn₩17.57bn₩5.42bn₩1.04bn₩12.85bn₩14.61bn
Diluted earnings per share633.91722.861,485.30849.00269.1851.79637.78726.09
Cash from operations₩1.45bn₩103.09bn−₩21.16bn₩29.25bn−₩11.45bn₩17.36bn₩55.73bn₩8.99bn
Capital spending−₩6.04bn−₩8.99bn−₩5.89bn−₩14.61bn−₩5.98bn−₩20.81bn−₩34.84bn−₩17.39bn
Free cash flow−₩4.59bn₩94.10bn−₩27.05bn₩14.64bn−₩17.43bn−₩3.45bn₩20.89bn−₩8.40bn
Total assets—₩849.94bn₩782.57bn₩755.49bn₩732.39bn₩742.16bn₩721.88bn₩691.59bn
Cash and short-term investments——————₩120.92bn₩97.89bn
Debt————₩45.50bn₩44.36bn₩74.77bn₩111.98bn
Shareholders' equity—₩611.60bn₩593.44bn₩556.62bn₩501.01bn₩494.71bn₩503.13bn₩488.12bn

Financial ratios

Data as of 26 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin17.7%—11.7%—3.4%-15.2%-28.6%-16.0%—
Net margin16.6%12.7%6.9%7.2%2.0%-9.8%———
Return on equity9.3%6.9%5.1%5.3%1.0%-4.1%———
Return on assets7.0%4.8%2.9%3.2%0.7%-2.7%———
Free cash flow yield——————-1.2%1.8%3.9%
Revenue growth21.2%-3.9%14.3%50.5%33.5%33.1%———
Earnings growth58.4%77.3%8.8%443.5%-127.3%-34.4%———
Current ratio2.26x2.48x4.16x1.47x3.24x12.66x———
Debt to equity—0.15x0.47x0.11x0.28x0.43x0.05x——
Equity ratio75.8%69.7%56.9%59.2%64.8%66.3%———
Interest coverage14.57x—5.48x—1.08x-29.19x———
R&D as a share of sales7.1%8.1%10.7%10.6%11.0%10.6%———
Buybacks as a share of market value——————0.0%3.2%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue10.0%21.7%9.2%
Operating income——4.0%
Net income45.1%—8.1%

Average margins

Over each period

1 year3 years5 years10 years
Net margin14.8%11.2%8.3%10.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings44.951.665.191.5—-159.4-30.0-39.914.213.5
Price to sales7.46.54.56.615.815.66.03.83.14.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2025FY2024FY2023FY2022FY2019FY2018FY2017
Paid in the year500.00500.00500.00500.00500.00500.00500.00500.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.